You are here

GSK

Gilead Could Be Making An Acquisition — But It's Not What You Think

Investors Business Daily

Fri, 08/4/17 - 11:56 am

Gilead Sciences

United Therapeutics

GlaxoSmithKline GLP-1 Tanzeum meets its end, and it doesn't bode well for Sanofi, AstraZeneca: analyst

Fierce Pharma

Tue, 08/1/17 - 10:48 pm

Vaccines provide a boost for GlaxoSmithKline, Sanofi and Merck in second-quarter financials

Fierce Pharma

Tue, 08/1/17 - 12:11 pm

Drugmaker GSK calls for at least two years' Brexit transition

Reuters

Sat, 07/29/17 - 09:39 am

GlaxoSmithKline's talk of leaving rare diseases—amid slow Strimvelis sales—highlights challenges in the field

Fierce Pharma

Thu, 07/27/17 - 07:33 pm

GSK gets go-ahead for new Benlysta formulation

BioPharma Dive

Wed, 07/26/17 - 10:20 pm

systemic lupus erythematosus

GSK CEO Walmsley is reorganizing R&D, dropping drugs and adding a new focus on cancer research

Endpoints

Wed, 07/26/17 - 09:52 am

GlaxoSmithKline Names Former Walmart Exec as New CTO

TheStreet.com

Tue, 07/25/17 - 09:41 am

Samsung Bioepis launches a Remicade knockoff at a 35% discount; FDA OK’s a self-administered version of Benlysta

Endpoints

Mon, 07/24/17 - 10:40 am

Samsung Bioepis

GSK to ax hundreds of jobs through manufacturing shuffle

BioPharma Dive

Thu, 07/20/17 - 06:15 pm

drug manufacturing

The flu vaccines are coming: GSK, Sanofi ship the first of more than 150M doses headed to U.S.

Fierce Pharma

Wed, 07/19/17 - 10:22 am

GSK puts old antibiotics and UK Horlicks business on the block

Yahoo/Reuters

Wed, 07/19/17 - 09:34 am

GlaxoSmithKline woos Pfizer medicinal sciences chief Tony Wood to high-level R&D job

Endpoints

Fri, 07/14/17 - 07:52 am

Ex-GSK CEO Andrew Witty goes biotech, taking a board seat at G1

Endpoints

Thu, 07/13/17 - 09:45 am

G1 Therapeutics

EuroBiotech Report: Brexit, BioNTech success, GlaxoSmithKline inks AI deal, Silence takes Alnylam to court and Shire makes cuts

Fierce Biotech

Thu, 07/6/17 - 05:58 pm

artificial intelligence

Silence Therapeutics

Ex-AstraZeneca executive Luke Miels accuses CEO Soriot of threatening him for taking GSK job

Fierce Pharma

Thu, 07/6/17 - 09:48 am

Can Merck knock Glaxo off its HIV perch? Maybe so, one analyst says

Fierce Pharma

Wed, 07/5/17 - 07:02 pm

Big pharma turns to AI to speed drug discovery, GSK signs deal

Yahoo/Reuters

Sun, 07/2/17 - 09:56 am

artificial intelligence

5 Biotech Stocks With Major Catalysts in July

Motley Fool

Wed, 06/28/17 - 11:03 pm

Puma Biotechnology

GlaxoSmithKline: 3 Reasons You Should Be Concerned

Seeking Alpha

Mon, 06/26/17 - 10:32 pm

Pages